| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.775 | 0.014 | 0.775 | Caspase 9 stimulant | |||
| 0.752 | 0.002 | 0.752 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 CID_187489 | ||
| 0.747 | 0.005 | 0.747 | Aldehyde oxidase inhibitor | 0.175 0.12 CID_187489 | ||
| 0.689 | 0.004 | 0.72 | Superoxide dismutase inhibitor | 0.72 0.004 CID_187489 | CID_187489 | |
| 0.653 | 0.012 | 0.708 | Cholesterol antagonist | 0.708 0.007 CID_187489 | CID_187489 | |
| 0.643 | 0.007 | 0.643 | Histamine release inhibitor | 0.542 0.018 CID_187489 | ||
| 0.579 | 0.017 | 0.579 | 5 Hydroxytryptamine release stimulant | |||
| 0.562 | 0.003 | 0.562 | 5 Hydroxytryptamine uptake stimulant | 0.273 0.061 CID_187489 | ||
| 0.573 | 0.035 | 0.573 | Transcription factor NF kappa B inhibitor | 0.339 0.08 CID_187489 | ||
| 0.555 | 0.018 | 0.555 | 5 Hydroxytryptamine release inhibitor | 0.258 0.217 CID_187489 | ||
| 0.57 | 0.033 | 0.57 | Cyclophilin D inhibitor | 0.562 0.035 CID_187489 | ||
| 0.555 | 0.02 | 0.555 | Vasodilator, peripheral | |||
| 0.538 | 0.014 | 0.538 | Lipoxygenase inhibitor | 0.187 0.155 CID_187489 | ||
| 0.545 | 0.023 | 0.663 | Antithrombotic | 0.663 0.01 CID_187489 | CID_187489 | |
| 0.524 | 0.007 | 0.524 | Monophenol monooxygenase inhibitor | 0.275 0.021 CID_187489 | ||
| 0.548 | 0.032 | 0.548 | 15-Lipoxygenase inhibitor | 0.365 0.091 CID_187489 | ||
| 0.529 | 0.013 | 0.529 | Free radical scavenger | 0.303 0.051 CID_187489 | ||
| 0.53 | 0.019 | 0.53 | 12-Lipoxygenase inhibitor | |||
| 0.519 | 0.008 | 0.519 | Peroxidase inhibitor | 0.158 0.074 CID_187489 | ||
| 0.507 | 0.007 | 0.507 | Melanin inhibitor | 0.153 0.078 CID_187489 | ||
| 0.51 | 0.019 | 0.51 | Antioxidant | 0.492 0.021 CID_187489 | ||
| 0.495 | 0.004 | 0.495 | Cystathionine beta-synthase inhibitor | 0.124 0.055 CID_187489 | ||
| 0.505 | 0.015 | 0.505 | Vasodilator, coronary | 0.262 0.123 CID_187489 | ||
| 0.49 | 0.003 | 0.49 | Succinate dehydrogenase inhibitor | 0.298 0.011 CID_187489 | ||
| 0.494 | 0.008 | 0.494 | Anesthetic general | |||
| 0.498 | 0.015 | 0.498 | Hypoglycemic | 0.202 0.111 CID_187489 | ||
| 0.487 | 0.022 | 0.487 | Apoptosis antagonist | 0.293 0.09 CID_187489 | ||
| 0.456 | 0.003 | 0.456 | Phenylalanine 4-hydroxylase inhibitor | 0.154 0.011 CID_187489 | ||
| 0.465 | 0.018 | 0.465 | Platelet antagonist | 0.448 0.019 CID_187489 | ||
| 0.453 | 0.013 | 0.453 | Platelet aggregation inhibitor | 0.202 0.08 CID_187489 | ||
| 0.434 | 0.009 | 0.434 | DNA methylase inhibitor | 0.136 0.131 CID_187489 | ||
| 0.428 | 0.007 | 0.428 | DNA methyltransferase I inhibitor | 0.144 0.111 CID_187489 | ||
| 0.422 | 0.012 | 0.422 | Sodium/bile acid cotransporter inhibitor | 0.399 0.017 CID_187489 | ||
| 0.431 | 0.021 | 0.431 | Amyloid beta aggregation inhibitor | |||
| 0.455 | 0.048 | 0.455 | Calcium channel L-type activator | 0.231 0.228 CID_187489 | ||
| 0.42 | 0.018 | 0.42 | Calcium channel activator | 0.301 0.091 CID_187489 | ||
| 0.407 | 0.005 | 0.407 | Neurotrophic factor enhancer | |||
| 0.432 | 0.034 | 0.432 | Spasmolytic | 0.274 0.081 CID_187489 | ||
| 0.405 | 0.009 | 0.405 | Amylase inhibitor | |||
| 0.475 | 0.082 | 0.475 | Apoptosis agonist | 0.253 0.211 CID_187489 | ||
| 0.401 | 0.013 | 0.401 | Non-steroidal antiinflammatory agent | 0.266 0.037 CID_187489 | ||
| 0.408 | 0.021 | 0.408 | Insulysin inhibitor | 0.278 0.073 CID_187489 | ||
| 0.392 | 0.009 | 0.392 | Protein kinase stimulant | 0.142 0.074 CID_187489 | ||
| 0.404 | 0.022 | 0.404 | Psychostimulant | |||
| 0.398 | 0.019 | 0.398 | Interleukin agonist | |||
| 0.382 | 0.003 | 0.382 | Vanilloid 1 agonist | 0.229 0.007 CID_187489 | ||
| 0.379 | 0.004 | 0.379 | Porphobilinogen synthase inhibitor | 0.175 0.016 CID_187489 | ||
| 0.423 | 0.049 | 0.423 | Thyroid hormone antagonist | |||
| 0.374 | 0.004 | 0.374 | Macrophage migration inhibitory factor inhibitor | 0.092 0.04 CID_187489 | ||
| 0.373 | 0.005 | 0.399 | Cholesterol synthesis inhibitor | 0.399 0.004 CID_187489 | CID_187489 | |
| 0.368 | 0.007 | 0.368 | Insulin secretagoues | 0.131 0.096 CID_187489 | ||
| 0.386 | 0.031 | 0.386 | Antiamyloidogenic | |||
| 0.361 | 0.009 | 0.361 | Insulin sensitizer | 0.234 0.044 CID_187489 | ||
| 0.383 | 0.049 | 0.383 | Caspase 3 stimulant | |||
| 0.337 | 0.009 | 0.337 | Phospholipase A2 inhibitor | 0.274 0.018 CID_187489 | ||
| 0.328 | 0.004 | 0.328 | Toll-Like receptor 2 antagonist | 0.116 0.082 CID_187489 | ||
| 0.439 | 0.116 | 0.439 | Antiinflammatory | 0.415 0.13 CID_187489 | ||
| 0.337 | 0.014 | 0.337 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.381 | 0.059 | 0.381 | Thyroid hormone beta antagonist | |||
| 0.347 | 0.026 | 0.347 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.328 | 0.008 | 0.328 | GABA C receptor agonist | 0.108 0.059 CID_187489 | ||
| 0.325 | 0.005 | 0.325 | Histidine decarboxylase inhibitor | |||
| 0.33 | 0.016 | 0.364 | Phospholipase C inhibitor | 0.364 0.013 CID_187489 | CID_187489 | |
| 0.356 | 0.043 | 0.356 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.335 | 0.023 | 0.435 | Platelet adhesion inhibitor | 0.435 0.009 CID_187489 | CID_187489 | |
| 0.314 | 0.008 | 0.314 | Expectorant | 0.128 0.045 CID_187489 | ||
| 0.309 | 0.003 | 0.309 | Glutamate decarboxylase inhibitor | 0.133 0.017 CID_187489 | ||
| 0.338 | 0.041 | 0.338 | Tumour necrosis factor alpha release inhibitor | 0.172 0.132 CID_187489 | ||
| 0.304 | 0.007 | 0.304 | Ferrochelatase inhibitor | 0.11 0.061 CID_187489 | ||
| 0.371 | 0.076 | 0.371 | Immunosuppressant | 0.264 0.138 CID_187489 | ||
| 0.338 | 0.045 | 0.338 | DNA damaging | |||
| 0.297 | 0.004 | 0.297 | Photosensitizer | 0.179 0.018 CID_187489 | ||
| 0.31 | 0.018 | 0.31 | Lipid peroxidase inhibitor | 0.195 0.044 CID_187489 | ||
| 0.317 | 0.029 | 0.317 | Growth hormone agonist | 0.149 0.088 CID_187489 | ||
| 0.326 | 0.04 | 0.526 | Angiogenesis stimulant | 0.526 0.01 CID_187489 | CID_187489 | |
| 0.286 | 0.003 | 0.286 | DOPA decarboxylase inhibitor | 0.123 0.042 CID_187489 | ||
| 0.323 | 0.042 | 0.323 | Hypolipemic | 0.225 0.079 CID_187489 | ||
| 0.291 | 0.012 | 0.291 | DNA polymerase I inhibitor | 0.163 0.042 CID_187489 | ||
| 0.284 | 0.004 | 0.284 | Keratolytic | |||
| 0.299 | 0.02 | 0.299 | Interferon gamma antagonist | |||
| 0.332 | 0.054 | 0.332 | Interleukin 2 agonist | 0.213 0.168 CID_187489 | ||
| 0.319 | 0.042 | 0.319 | Vasodilator | |||
| 0.281 | 0.006 | 0.281 | Carbonic anhydrase III inhibitor | 0.191 0.018 CID_187489 | ||
| 0.33 | 0.056 | 0.33 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.293 | 0.02 | 0.293 | Tubulin antagonist | 0.173 0.048 CID_187489 | ||
| 0.304 | 0.03 | 0.304 | Gastrin inhibitor | 0.229 0.106 CID_187489 | ||
| 0.352 | 0.081 | 0.352 | Toll-Like receptor agonist | |||
| 0.351 | 0.081 | 0.351 | Toll-Like receptor 7 agonist | |||
| 0.273 | 0.006 | 0.273 | Alcohol dehydrogenase inhibitor | 0.092 0.062 CID_187489 | ||
| 0.274 | 0.007 | 0.655 | Carbonic anhydrase XIII inhibitor | 0.655 0.003 CID_187489 | CID_187489 | |
| 0.27 | 0.004 | 0.27 | HIV-1 integrase (Overall Integration) inhibitor | 0.166 0.02 CID_187489 | ||
| 0.27 | 0.005 | 0.27 | Mucolytic | 0.146 0.035 CID_187489 | ||
| 0.332 | 0.07 | 0.394 | Immunostimulant | 0.394 0.051 CID_187489 | CID_187489 | |
| 0.27 | 0.008 | 0.27 | Carbonic anhydrase VI inhibitor | 0.163 0.018 CID_187489 | ||
| 0.27 | 0.011 | 0.27 | Interleukin 4 antagonist | |||
| 0.304 | 0.047 | 0.304 | Pyruvate kinase inhibitor | |||
| 0.288 | 0.031 | 0.462 | Dual specificity phosphatase inhibitor | 0.462 0.009 CID_187489 | CID_187489 | |
| 0.275 | 0.019 | 0.275 | Nitric-oxide synthase stimulant | |||
| 0.256 | 0.003 | 0.256 | GABA B receptor agonist | 0.11 0.011 CID_187489 | ||
| 0.255 | 0.008 | 0.255 | Cyclooxygenase 3 inhibitor | |||
| 0.26 | 0.014 | 0.26 | Cell adhesion inhibitor | 0.212 0.022 CID_187489 | ||
| 0.287 | 0.043 | 0.287 | Nitric oxide antagonist | 0.176 0.079 CID_187489 | ||
| 0.277 | 0.034 | 0.277 | P-glycoprotein inhibitor | |||
| 0.245 | 0.004 | 0.245 | Adenylate cyclase stimulant | 0.21 0.01 CID_187489 | ||
| 0.277 | 0.036 | 0.277 | Hepatoprotectant | 0.274 0.037 CID_187489 | ||
| 0.273 | 0.034 | 0.461 | Dual specificity phosphatase 3 inhibitor | 0.461 0.009 CID_187489 | CID_187489 | |
| 0.258 | 0.019 | 0.258 | NADPH oxidase inhibitor | |||
| 0.243 | 0.005 | 0.243 | Vanilloid agonist | 0.127 0.015 CID_187489 | ||
| 0.253 | 0.015 | 0.253 | 5-Lipoxygenase inhibitor | |||
| 0.245 | 0.01 | 0.245 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.082 0.077 CID_187489 | ||
| 0.262 | 0.028 | 0.429 | Protein-tyrosine phosphatase inhibitor | 0.429 0.007 CID_187489 | CID_187489 | |
| 0.239 | 0.008 | 0.239 | Arachidonic acid antagonist | 0.192 0.04 CID_187489 | ||
| 0.232 | 0.005 | 0.232 | Leukotriene antagonist | 0.167 0.008 CID_187489 | ||
| 0.243 | 0.022 | 0.243 | Neurotensin receptor agonist | 0.156 0.088 CID_187489 | ||
| 0.244 | 0.024 | 0.244 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.251 | 0.033 | 0.297 | Thrombolytic | 0.297 0.024 CID_187489 | CID_187489 | |
| 0.221 | 0.005 | 0.221 | Heat shock protein 70 antagonist | |||
| 0.231 | 0.014 | 0.231 | Bronchodilator | |||
| 0.268 | 0.055 | 0.268 | Interleukin antagonist | |||
| 0.23 | 0.019 | 0.23 | Chelator | |||
| 0.228 | 0.026 | 0.228 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.204 | 0.004 | 0.204 | Leukotriene B4 antagonist | 0.201 0.004 CID_187489 | ||
| 0.201 | 0.006 | 0.201 | Prostaglandin EP2 antagonist | 0.067 0.035 CID_187489 | ||
| 0.202 | 0.008 | 0.202 | Prolactin inhibitor | |||
| 0.199 | 0.012 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.204 | 0.018 | 0.204 | Carbonic anhydrase XV inhibitor | 0.111 0.054 CID_187489 | ||
| 0.195 | 0.011 | 0.195 | TRPA1 agonist | 0.177 0.017 CID_187489 | ||
| 0.193 | 0.009 | 0.193 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 CID_187489 | ||
| 0.209 | 0.027 | 0.279 | Protein-tyrosine phosphatase 1B inhibitor | 0.279 0.013 CID_187489 | CID_187489 | |
| 0.207 | 0.027 | 0.207 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.195 | 0.016 | 0.267 | Catalase inhibitor | 0.267 0.008 CID_187489 | CID_187489 | |
| 0.193 | 0.016 | 0.193 | Mediator release inhibitor | |||
| 0.203 | 0.027 | 0.203 | Aldehyde dehydrogenase inhibitor | |||
| 0.218 | 0.043 | 0.218 | Tumour necrosis factor antagonist | |||
| 0.179 | 0.005 | 0.179 | GABA aminotransferase inhibitor | |||
| 0.238 | 0.064 | 0.238 | Antimitotic | 0.227 0.07 CID_187489 | ||
| 0.18 | 0.008 | 0.18 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 CID_187489 | ||
| 0.233 | 0.061 | 0.279 | RNA-directed DNA polymerase inhibitor | 0.279 0.037 CID_187489 | CID_187489 | |
| 0.206 | 0.034 | 0.206 | Bone formation stimulant | 0.108 0.098 CID_187489 | ||
| 0.176 | 0.006 | 0.176 | Ornithine decarboxylase inhibitor | 0.081 0.066 CID_187489 | ||
| 0.248 | 0.084 | 0.248 | Transcription factor STAT3 inhibitor | |||
| 0.197 | 0.034 | 0.197 | Catenin beta inhibitor | |||
| 0.211 | 0.05 | 0.211 | Mcl-1 antagonist | |||
| 0.192 | 0.031 | 0.192 | Neurotrophic factor | |||
| 0.229 | 0.068 | 0.229 | Peptidyltransferase inhibitor | |||
| 0.165 | 0.005 | 0.165 | Bile acid receptor antagonist | 0.162 0.006 CID_187489 | ||
| 0.186 | 0.027 | 0.186 | Farnesoid X receptor antagonist | 0.12 0.103 CID_187489 | ||
| 0.181 | 0.024 | 0.181 | Xanthine oxidase inhibitor | |||
| 0.175 | 0.018 | 0.334 | Cathepsin G inhibitor | 0.334 0.008 CID_187489 | CID_187489 | |
| 0.17 | 0.013 | 0.17 | Electron transport complex I inhibitor | 0.1 0.083 CID_187489 | ||
| 0.168 | 0.015 | 0.168 | Phosphofructokinase-1 inhibitor | 0.092 0.035 CID_187489 | ||
| 0.195 | 0.043 | 0.195 | NOS3 expression enhancer | |||
| 0.155 | 0.006 | 0.155 | Purinergic P2X1 antagonist | 0.088 0.021 CID_187489 | ||
| 0.164 | 0.015 | 0.164 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.159 | 0.01 | 0.159 | Glutathione S-transferase inhibitor | |||
| 0.165 | 0.016 | 0.436 | Triose-phosphate isomerase inhibitor | 0.436 0.003 CID_187489 | CID_187489 | |
| 0.168 | 0.02 | 0.168 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.155 | 0.009 | 0.155 | Biliverdin reductase inhibitor | |||
| 0.151 | 0.005 | 0.151 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.159 | 0.013 | 0.2 | Cell adhesion molecule inhibitor | 0.2 0.009 CID_187489 | CID_187489 | |
| 0.185 | 0.039 | 0.511 | Hemostatic | 0.511 0.004 CID_187489 | CID_187489 | |
| 0.164 | 0.019 | 0.164 | Uric acid excretion stimulant | |||
| 0.165 | 0.019 | 0.203 | Breast cancer-resistant protein inhibitor | 0.203 0.013 CID_187489 | CID_187489 | |
| 0.155 | 0.01 | 0.155 | Alcohol oxidase inhibitor | |||
| 0.149 | 0.004 | 0.149 | Estrogen-related receptor beta agonist | 0.08 0.067 CID_187489 | ||
| 0.163 | 0.019 | 0.163 | Creatine kinase inhibitor | |||
| 0.157 | 0.014 | 0.157 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.162 | 0.02 | 0.162 | Caspase 3 inhibitor | |||
| 0.152 | 0.012 | 0.152 | Beta tubulin antagonist | |||
| 0.145 | 0.005 | 0.145 | Plasminogen activator inhibitor antagonist | |||
| 0.161 | 0.022 | 0.161 | Ca2+-transporting ATPase inhibitor | |||
| 0.169 | 0.03 | 0.219 | Aminopeptidase B inhibitor | 0.219 0.017 CID_187489 | CID_187489 | |
| 0.144 | 0.007 | 0.144 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.225 | 0.088 | 0.225 | DNA synthesis inhibitor | |||
| 0.284 | 0.148 | 0.414 | Antibacterial | 0.414 0.071 CID_187489 | CID_187489 | |
| 0.194 | 0.061 | 0.194 | Amyloid beta precursor protein antagonist | |||
| 0.146 | 0.013 | 0.216 | CDC25A inhibitor | 0.216 0.005 CID_187489 | CID_187489 | |
| 0.146 | 0.014 | 0.305 | HIV-1 integrase (3'-Processing) inhibitor | 0.305 0.005 CID_187489 | CID_187489 | |
| 0.135 | 0.005 | 0.135 | Peroxisome proliferator-activated receptor delta antagonist | 0.039 0.015 CID_187489 | ||
| 0.183 | 0.054 | 0.183 | ATPase inhibitor | |||
| 0.152 | 0.024 | 0.269 | Multidrug resistance-associated protein 1 inhibitor | 0.269 0.004 CID_187489 | CID_187489 | |
| 0.142 | 0.016 | 0.349 | Carbonic anhydrase V inhibitor | 0.349 0.003 CID_187489 | CID_187489 | |
| 0.135 | 0.009 | 0.135 | Glycine receptor agonist | 0.074 0.048 CID_187489 | ||
| 0.189 | 0.064 | 0.189 | Lipocortins synthesis antagonist | |||
| 0.158 | 0.033 | 0.158 | Microtubule formation inhibitor | |||
| 0.152 | 0.027 | 0.152 | AMP-activated protein kinase stimulant | |||
| 0.146 | 0.023 | 0.146 | Toll-Like receptor 4 antagonist | |||
| 0.13 | 0.008 | 0.13 | Beta adrenoreceptor antagonist | |||
| 0.134 | 0.012 | 0.134 | Leukotriene synthesis inhibitor | |||
| 0.143 | 0.022 | 0.161 | Anabolic | 0.161 0.013 CID_187489 | CID_187489 | |
| 0.125 | 0.004 | 0.125 | Free fatty acid receptor 1 agonist | 0.035 0.005 CID_187489 | ||
| 0.132 | 0.011 | 0.132 | Alpha tubulin antagonist | |||
| 0.168 | 0.049 | 0.168 | CF transmembrane conductance regulator agonist | |||
| 0.129 | 0.01 | 0.129 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.145 | 0.027 | 0.145 | Sphingomyelinase inhibitor | |||
| 0.16 | 0.042 | 0.16 | Alkylator | 0.125 0.064 CID_187489 | ||
| 0.127 | 0.009 | 0.127 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.055 CID_187489 | ||
| 0.132 | 0.014 | 0.335 | HIV-1 integrase (Strand Transfer) inhibitor | 0.335 0.004 CID_187489 | CID_187489 | |
| 0.151 | 0.033 | 0.151 | Interleukin 8 antagonist | |||
| 0.132 | 0.015 | 0.25 | Carbonic anhydrase VA inhibitor | 0.25 0.004 CID_187489 | CID_187489 | |
| 0.135 | 0.019 | 0.135 | Glutamate (mGluR7) agonist | |||
| 0.157 | 0.041 | 0.157 | Antibacterial (Helicobacter pylori) | 0.12 0.082 CID_187489 | ||
| 0.165 | 0.051 | 0.183 | Alkaline phosphatase inhibitor | 0.183 0.041 CID_187489 | CID_187489 | |
| 0.127 | 0.013 | 0.127 | Aldose reductase inhibitor | 0.121 0.014 CID_187489 | ||
| 0.161 | 0.049 | 0.161 | M17 leucyl aminopeptidase inhibitor | |||
| 0.132 | 0.021 | 0.132 | Adrenaline agonist | |||
| 0.128 | 0.017 | 0.128 | Aminopeptidase I inhibitor | |||
| 0.17 | 0.061 | 0.506 | Diuretic | 0.506 0.007 CID_187489 | CID_187489 | |
| 0.115 | 0.006 | 0.115 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.028 CID_187489 | ||
| 0.164 | 0.057 | 0.164 | GABA C receptor rho-2 antagonist | |||
| 0.137 | 0.032 | 0.137 | Adenylate kinase inhibitor | 0.101 0.065 CID_187489 | ||
| 0.12 | 0.015 | 0.13 | HIV-1 integrase inhibitor | 0.13 0.012 CID_187489 | CID_187489 | |
| 0.218 | 0.115 | 0.218 | Transcription factor STAT inhibitor | |||
| 0.133 | 0.03 | 0.133 | Folate antagonist | |||
| 0.114 | 0.011 | 0.114 | Beta 3 adrenoreceptor antagonist | |||
| 0.109 | 0.007 | 0.109 | Glutamate (mGluR7) antagonist | |||
| 0.11 | 0.008 | 0.11 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.003 | 0.105 | Free fatty acid receptor 1 antagonist | 0.049 0.01 CID_187489 | ||
| 0.118 | 0.017 | 0.118 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.148 | 0.048 | 0.148 | Proteasome inhibitor | |||
| 0.115 | 0.014 | 0.115 | Prostaglandin antagonist | |||
| 0.147 | 0.047 | 0.147 | Adenylate cyclase inhibitor | |||
| 0.104 | 0.005 | 0.104 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.121 | 0.022 | 0.121 | Glutamate dehydrogenase inhibitor | 0.075 0.05 CID_187489 | ||
| 0.14 | 0.042 | 0.14 | Falcipain 3 inhibitor | |||
| 0.111 | 0.013 | 0.111 | Maillard reaction inhibitor | |||
| 0.107 | 0.009 | 0.107 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 CID_187489 | ||
| 0.25 | 0.154 | 0.25 | GABA C receptor rho-3 antagonist | |||
| 0.102 | 0.008 | 0.102 | Aconitate hydratase inhibitor | 0.047 0.044 CID_187489 | ||
| 0.185 | 0.092 | 0.185 | Histone acetyltransferase inhibitor | |||
| 0.131 | 0.038 | 0.131 | Estrogen antagonist | |||
| 0.121 | 0.028 | 0.121 | NADH dehydrogenase inhibitor | 0.079 0.078 CID_187489 | ||
| 0.097 | 0.005 | 0.097 | Vanilloid 2 antagonist | 0.068 0.015 CID_187489 | ||
| 0.102 | 0.01 | 0.102 | Thromboxane antagonist | |||
| 0.12 | 0.029 | 0.12 | Interleukin 12 antagonist | |||
| 0.129 | 0.037 | 0.167 | Gastric antisecretory | 0.167 0.02 CID_187489 | CID_187489 | |
| 0.097 | 0.007 | 0.097 | Thromboxane synthase inhibitor | |||
| 0.097 | 0.007 | 0.097 | Glucose-6-phosphate translocase inhibitor | |||
| 0.093 | 0.005 | 0.093 | Leukotriene C antagonist | 0.053 0.052 CID_187489 | ||
| 0.268 | 0.18 | 0.268 | DNA directed DNA polymerase inhibitor | |||
| 0.161 | 0.074 | 0.161 | Interleukin 6 antagonist | |||
| 0.091 | 0.005 | 0.091 | Ryanodine receptor antagonist | |||
| 0.115 | 0.029 | 0.115 | Phosphodiesterase 6D inhibitor | 0.087 0.083 CID_187489 | ||
| 0.112 | 0.026 | 0.112 | ATPase (Vacuolar H+) inhibitor | |||
| 0.094 | 0.009 | 0.094 | Beta 2 adrenoreceptor antagonist | |||
| 0.144 | 0.06 | 0.144 | Cyclooxygenase 1 inhibitor | 0.123 0.077 CID_187489 | ||
| 0.103 | 0.02 | 0.103 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 CID_187489 | ||
| 0.093 | 0.009 | 0.093 | Thromboxane A2 antagonist | |||
| 0.098 | 0.016 | 0.098 | CDC25B inhibitor | |||
| 0.116 | 0.034 | 0.116 | Thioredoxin inhibitor | |||
| 0.086 | 0.005 | 0.086 | Dopamine D5 agonist | |||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | |||
| 0.095 | 0.014 | 0.095 | Prostaglandin F2 alpha antagonist | |||
| 0.108 | 0.027 | 0.108 | Myeloperoxidase inhibitor | |||
| 0.134 | 0.053 | 0.134 | Beta amyloid protein antagonist | |||
| 0.084 | 0.004 | 0.084 | ATP citrate lysase inhibitor | |||
| 0.084 | 0.005 | 0.084 | Glutamate (mGluR3) antagonist | |||
| 0.082 | 0.003 | 0.093 | Thyroid hormone agonist | 0.093 0.003 CID_187489 | CID_187489 | |
| 0.114 | 0.035 | 0.114 | ABCA1 expression enhancer | |||
| 0.084 | 0.006 | 0.084 | Liver X receptor alpha agonist | |||
| 0.083 | 0.007 | 0.083 | Prostaglandin EP3 antagonist | |||
| 0.082 | 0.006 | 0.082 | Prostaglandin agonist | |||
| 0.152 | 0.076 | 0.152 | Hexokinase inhibitor | |||
| 0.115 | 0.039 | 0.115 | Estrogen receptor beta antagonist | |||
| 0.102 | 0.027 | 0.102 | D-Ala-D-Ala ligase inhibitor | |||
| 0.09 | 0.015 | 0.09 | Glycine transporter 2 inhibitor | |||
| 0.093 | 0.018 | 0.144 | Carbonic anhydrase VB inhibitor | 0.144 0.009 CID_187489 | CID_187489 | |
| 0.077 | 0.003 | 0.077 | G-protein-coupled receptor 120 agonist | 0.018 0.011 CID_187489 | ||
| 0.1 | 0.028 | 0.1 | Caspase 7 inhibitor | |||
| 0.107 | 0.035 | 0.107 | Metalloproteinase-2 inhibitor | |||
| 0.076 | 0.004 | 0.076 | Leukotriene B4 receptor 1 antagonist | 0.035 0.014 CID_187489 | ||
| 0.129 | 0.057 | 0.129 | DNA repair enzyme inhibitor | |||
| 0.192 | 0.121 | 0.192 | Calpain inhibitor | |||
| 0.12 | 0.048 | 0.169 | Acetylcholine release stimulant | 0.169 0.008 CID_187489 | CID_187489 | |
| 0.154 | 0.083 | 0.154 | Sigma receptor agonist | |||
| 0.099 | 0.028 | 0.099 | Estrogen receptor alpha antagonist | |||
| 0.195 | 0.124 | 0.195 | Cardiotonic | |||
| 0.075 | 0.004 | 0.075 | Glutamate (mGluR8) agonist | |||
| 0.088 | 0.017 | 0.088 | Transcription factor AP-1 inhibitor | |||
| 0.079 | 0.01 | 0.079 | Lysophosphatidic acid 3 receptor antagonist | 0.057 0.026 CID_187489 | ||
| 0.091 | 0.023 | 0.139 | NMDA receptor agonist | 0.139 0.009 CID_187489 | CID_187489 | |
| 0.109 | 0.041 | 0.109 | Calcium antagonist | |||
| 0.104 | 0.037 | 0.104 | Glutamate release inhibitor | |||
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.107 | 0.04 | 0.107 | Phosphodiesterase IV inhibitor | |||
| 0.075 | 0.009 | 0.075 | Urate transporter 1 inhibitor | |||
| 0.078 | 0.012 | 0.078 | DNA helicase inhibitor | 0.054 0.039 CID_187489 | ||
| 0.075 | 0.01 | 0.075 | Pregnane X receptor antagonist | |||
| 0.075 | 0.01 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 CID_187489 | ||
| 0.254 | 0.19 | 0.254 | DNA polymerase beta inhibitor | |||
| 0.114 | 0.051 | 0.114 | Beta glucuronidase inhibitor | |||
| 0.071 | 0.008 | 0.071 | Fumarate hydratase inhibitor | |||
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | |||
| 0.067 | 0.005 | 0.067 | Catechol O-methyltransferase inhibitor | |||
| 0.078 | 0.017 | 0.078 | Calcium channel P-type blocker | |||
| 0.069 | 0.008 | 0.069 | Dopamine beta hydroxylase inhibitor | |||
| 0.069 | 0.009 | 0.069 | Retinoid X alpha receptor agonist | |||
| 0.071 | 0.011 | 0.071 | Sphingosine 1-phosphate receptor agonist | |||
| 0.083 | 0.024 | 0.083 | Argininosuccinate synthase inhibitor | |||
| 0.109 | 0.051 | 0.109 | GABA C receptor rho-1 antagonist | |||
| 0.066 | 0.008 | 0.087 | Dihydrofolate reductase inhibitor | 0.087 0.004 CID_187489 | CID_187489 | |
| 0.063 | 0.005 | 0.063 | Leukotriene C4 antagonist | |||
| 0.115 | 0.057 | 0.166 | Nav1.4 sodium channel blocker | 0.166 0.028 CID_187489 | CID_187489 | |
| 0.064 | 0.007 | 0.064 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.063 | 0.006 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.034 CID_187489 | ||
| 0.139 | 0.082 | 0.139 | Thiol protease inhibitor | |||
| 0.067 | 0.011 | 0.067 | Retinoid X receptor agonist | |||
| 0.081 | 0.025 | 0.081 | Carbonic anhydrase stimulant | |||
| 0.079 | 0.025 | 0.079 | Xanthine dehydrogenase inhibitor | |||
| 0.091 | 0.037 | 0.091 | Metalloproteinase-9 inhibitor | |||
| 0.092 | 0.039 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 CID_187489 | CID_187489 | |
| 0.064 | 0.011 | 0.064 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.055 | 0.003 | 0.055 | Prostaglandin H2 antagonist | 0.035 0.009 CID_187489 | ||
| 0.055 | 0.004 | 0.055 | Thyroid hormone alpha antagonist | |||
| 0.106 | 0.055 | 0.106 | UDP-glucose 4-epimerase inhibitor | |||
| 0.065 | 0.015 | 0.065 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.13 | 0.08 | 0.13 | Cytokine production inhibitor | |||
| 0.054 | 0.004 | 0.054 | Prostaglandin F2 alpha agonist | |||
| 0.061 | 0.011 | 0.061 | Phosphoglycerate kinase inhibitor | 0.06 0.011 CID_187489 | ||
| 0.057 | 0.007 | 0.057 | Prostaglandin EP4 antagonist | |||
| 0.06 | 0.011 | 0.06 | Dihydropteroate synthase inhibitor | |||
| 0.065 | 0.016 | 0.11 | Heparanase inhibitor | 0.11 0.004 CID_187489 | CID_187489 | |
| 0.057 | 0.009 | 0.057 | Kainate receptor agonist | |||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | |||
| 0.055 | 0.007 | 0.055 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | |||
| 0.057 | 0.01 | 0.057 | Prostacyclin antagonist | |||
| 0.065 | 0.018 | 0.065 | CD45 antagonist | |||
| 0.066 | 0.019 | 0.091 | Adenine nucleotide translocase inhibitor | 0.091 0.005 CID_187489 | CID_187489 | |
| 0.05 | 0.004 | 0.05 | Lysophosphatidic acid 1 receptor antagonist | 0.027 0.008 CID_187489 | ||
| 0.064 | 0.018 | 0.064 | NMDA receptor subunit 3B antagonist | |||
| 0.121 | 0.074 | 0.121 | Cathepsin H inhibitor | |||
| 0.053 | 0.008 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.052 | 0.007 | 0.052 | Vanilloid 3 antagonist | |||
| 0.076 | 0.031 | 0.076 | NMDA receptor glycine site agonist | |||
| 0.052 | 0.008 | 0.052 | Liver X receptor beta antagonist | |||
| 0.054 | 0.009 | 0.054 | Leukotriene D4 antagonist | |||
| 0.238 | 0.195 | 0.238 | Alpha-glucosidase inhibitor | |||
| 0.048 | 0.004 | 0.048 | Leukotriene B4 receptor 2 antagonist | |||
| 0.05 | 0.007 | 0.13 | Kynurenine 3 monooxygenase inhibitor | 0.13 0.003 CID_187489 | CID_187489 | |
| 0.115 | 0.072 | 0.115 | Topoisomerase II inhibitor | |||
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | |||
| 0.086 | 0.044 | 0.086 | Interferon agonist | 0.085 0.045 CID_187489 | ||
| 0.136 | 0.094 | 0.572 | Anticoagulant | 0.572 0.007 CID_187489 | CID_187489 | |
| 0.083 | 0.04 | 0.083 | Lipase inhibitor | |||
| 0.048 | 0.006 | 0.048 | Prostaglandin E2 agonist | |||
| 0.057 | 0.016 | 0.057 | AICAR transformylase inhibitor | 0.046 0.028 CID_187489 | ||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | |||
| 0.064 | 0.023 | 0.064 | Integrin antagonist | |||
| 0.057 | 0.017 | 0.057 | NMDA receptor subunit 3A antagonist | |||
| 0.063 | 0.023 | 0.063 | Bombesin 2 receptor antagonist | |||
| 0.072 | 0.032 | 0.072 | MDM2 inhibitor | |||
| 0.068 | 0.028 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.069 | 0.029 | 0.069 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.044 | 0.005 | 0.044 | Prostaglandin EP4 agonist | |||
| 0.07 | 0.031 | 0.07 | Ribonucleotide reductase inhibitor | |||
| 0.045 | 0.008 | 0.045 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.086 | 0.048 | 0.086 | Thioredoxin reductase inhibitor | |||
| 0.052 | 0.015 | 0.052 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.076 | 0.039 | 0.245 | Selectin antagonist | 0.245 0.008 CID_187489 | CID_187489 | |
| 0.122 | 0.085 | 0.122 | Interleukin 1 antagonist | |||
| 0.044 | 0.007 | 0.044 | Prostaglandin EP2 agonist | |||
| 0.119 | 0.084 | 0.119 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.089 | 0.055 | 0.107 | NMDA receptor antagonist | 0.107 0.042 CID_187489 | CID_187489 | |
| 0.109 | 0.075 | 0.109 | Anesthetic local | |||
| 0.102 | 0.068 | 0.102 | Topoisomerase I inhibitor | |||
| 0.068 | 0.035 | 0.075 | NMDA 2C receptor antagonist | 0.075 0.029 CID_187489 | CID_187489 | |
| 0.084 | 0.05 | 0.084 | Topoisomerase II alpha inhibitor | |||
| 0.064 | 0.032 | 0.07 | Sphingosine kinase inhibitor | 0.07 0.025 CID_187489 | CID_187489 | |
| 0.062 | 0.03 | 0.062 | Sphingosine kinase 2 inhibitor | |||
| 0.045 | 0.014 | 0.045 | VCAM-1 antagonist | |||
| 0.073 | 0.042 | 0.073 | Matrix metalloproteinase inhibitor | |||
| 0.07 | 0.039 | 0.07 | Neutrophil collagenase inhibitor | |||
| 0.045 | 0.014 | 0.045 | VCAM antagonist | |||
| 0.045 | 0.014 | 0.045 | VLA-4 antagonist | |||
| 0.047 | 0.016 | 0.047 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.033 | 0.003 | 0.033 | Thyroid hormone beta agonist | |||
| 0.043 | 0.014 | 0.043 | Glutamate (mGluR8) antagonist | |||
| 0.059 | 0.03 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.052 | 0.023 | 0.075 | Mannosidase inhibitor | 0.075 0.01 CID_187489 | CID_187489 | |
| 0.035 | 0.006 | 0.035 | Vanilloid 2 agonist | 0.032 0.007 CID_187489 | ||
| 0.033 | 0.005 | 0.033 | Ileal bile acid transport inhibitor | |||
| 0.066 | 0.038 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.086 | 0.057 | 0.086 | Transcription factor NF kappa B stimulant | |||
| 0.045 | 0.017 | 0.045 | Retinoid X receptor antagonist | |||
| 0.064 | 0.036 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.058 | 0.03 | 0.076 | Alpha-mannosidase inhibitor | 0.076 0.013 CID_187489 | CID_187489 | |
| 0.073 | 0.045 | 0.073 | Prostaglandin-E synthase inhibitor | |||
| 0.041 | 0.014 | 0.041 | Carnitine palmitoyltransferase inhibitor | |||
| 0.085 | 0.059 | 0.085 | Antineoplastic alkaloid | |||
| 0.046 | 0.02 | 0.046 | 5-Alpha-reductase inhibitor | |||
| 0.071 | 0.045 | 0.071 | Elastase 1 inhibitor | |||
| 0.077 | 0.052 | 0.077 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | Integrin alpha4 antagonist | |||
| 0.122 | 0.097 | 0.122 | Cyclooxygenase inhibitor | |||
| 0.052 | 0.027 | 0.052 | Potassium channel Kv1.3 blocker | |||
| 0.042 | 0.017 | 0.042 | Squalene synthetase inhibitor | 0.04 0.018 CID_187489 | ||
| 0.064 | 0.04 | 0.064 | Caspase 9 inhibitor | |||
| 0.036 | 0.012 | 0.036 | Liver X receptor alpha antagonist | |||
| 0.038 | 0.014 | 0.038 | Prostaglandin D2 agonist | |||
| 0.027 | 0.003 | 0.027 | Glutamate (mGluR6) agonist | |||
| 0.027 | 0.004 | 0.027 | Thyroid hormone alpha agonist | |||
| 0.079 | 0.057 | 0.079 | Platelet growth factor antagonist | |||
| 0.039 | 0.017 | 0.039 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.066 | 0.044 | 0.066 | Glucagon-like peptide 1 agonist | |||
| 0.05 | 0.029 | 0.05 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.036 | 0.016 | 0.036 | Glucagon receptor antagonist | |||
| 0.046 | 0.027 | 0.046 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.037 | 0.018 | 0.037 | Liver X receptor beta agonist | |||
| 0.046 | 0.027 | 0.046 | Macrophage elastase inhibitor | |||
| 0.037 | 0.018 | 0.037 | Melatonin receptor 1A agonist | |||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.078 | 0.06 | 0.13 | Glycine receptor antagonist | 0.13 0.014 CID_187489 | CID_187489 | |
| 0.04 | 0.022 | 0.04 | Arginase inhibitor | |||
| 0.045 | 0.027 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.051 | 0.033 | 0.051 | Factor III inhibitor | |||
| 0.064 | 0.046 | 0.064 | Interferon inducer | 0.064 0.044 CID_187489 | ||
| 0.043 | 0.026 | 0.043 | Plasmepsin II inhibitor | |||
| 0.041 | 0.024 | 0.041 | GABA uptake inhibitor | |||
| 0.055 | 0.038 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.099 | 0.082 | 0.099 | Interleukin 1b antagonist | |||
| 0.083 | 0.067 | 0.083 | Interleukin 5 antagonist | |||
| 0.054 | 0.037 | 0.054 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.027 | 0.011 | 0.027 | Beta 1 adrenoreceptor agonist | |||
| 0.048 | 0.032 | 0.048 | Adenosine deaminase inhibitor | |||
| 0.03 | 0.014 | 0.03 | Calcium-sensing receptor agonist | |||
| 0.023 | 0.007 | 0.023 | Calcium-sensing receptor antagonist | |||
| 0.05 | 0.035 | 0.05 | Prostaglandin E2 antagonist | |||
| 0.085 | 0.07 | 0.085 | Potassium channel (Ca-activated) activator | |||
| 0.068 | 0.052 | 0.068 | Amidase inhibitor | |||
| 0.054 | 0.039 | 0.054 | Epithelial sodium channel blocker | |||
| 0.035 | 0.019 | 0.035 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.043 | 0.029 | 0.056 | Guanylate cyclase inhibitor | 0.056 0.016 CID_187489 | CID_187489 | |
| 0.05 | 0.035 | 0.147 | Estrogen agonist | 0.147 0.011 CID_187489 | CID_187489 | |
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | |||
| 0.05 | 0.036 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.02 | 0.006 | 0.02 | Thromboxane A2 agonist | |||
| 0.048 | 0.035 | 0.054 | Metalloproteinase-3 inhibitor | 0.054 0.029 CID_187489 | CID_187489 | |
| 0.022 | 0.008 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.035 | 0.022 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Liver X receptor antagonist | |||
| 0.048 | 0.036 | 0.048 | Topoisomerase II beta inhibitor | |||
| 0.043 | 0.03 | 0.043 | Glutamate (mGluR group III) agonist | |||
| 0.021 | 0.009 | 0.021 | Antibiotic Anthracycline-like | |||
| 0.024 | 0.012 | 0.024 | Integrin alpha4beta7 antagonist | |||
| 0.034 | 0.023 | 0.034 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.045 | 0.034 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.016 | 0.006 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.049 | 0.039 | 0.049 | NMDA 2A receptor antagonist | |||
| 0.029 | 0.019 | 0.029 | Uridine phosphorylase inhibitor | |||
| 0.056 | 0.047 | 0.056 | Collagenase 3 inhibitor | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin D2 antagonist | |||
| 0.014 | 0.005 | 0.014 | Thromboxane agonist | |||
| 0.115 | 0.107 | 0.255 | Cell wall synthesis inhibitor | 0.255 0.015 CID_187489 | CID_187489 | |
| 0.06 | 0.052 | 0.06 | Purinergic P2X2 antagonist | |||
| 0.016 | 0.007 | 0.016 | Integrin beta6 antagonist | |||
| 0.036 | 0.029 | 0.041 | Farnesoid X receptor agonist | 0.041 0.023 CID_187489 | CID_187489 | |
| 0.107 | 0.1 | 0.127 | Nav1.2 sodium channel blocker | 0.127 0.075 CID_187489 | CID_187489 | |
| 0.076 | 0.07 | 0.076 | Inducible nitric-oxide synthase inhibitor | |||
| 0.033 | 0.027 | 0.033 | HMG CoA reductase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Integrin beta5 antagonist | |||
| 0.03 | 0.024 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.035 | 0.03 | 0.035 | Integrin alpha2 antagonist | |||
| 0.016 | 0.011 | 0.016 | Prostacyclin agonist | |||
| 0.049 | 0.044 | 0.049 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.037 | 0.034 | 0.037 | Integrin alpha5beta1 antagonist | |||
| 0.033 | 0.03 | 0.033 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.078 | 0.075 | 0.078 | T cell inhibitor | |||
| 0.042 | 0.039 | 0.042 | GP IIb/IIIa receptor antagonist | |||
| 0.025 | 0.022 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.064 | 0.061 | 0.064 | Phosphodiesterase 4D inhibitor | |||
| 0.058 | 0.056 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | 0.067 0.041 CID_187489 | CID_187489 | |
| 0.036 | 0.034 | 0.036 | Integrin alpha1beta1 antagonist | |||
| 0.041 | 0.039 | 0.041 | Antimetabolite | |||
| 0.03 | 0.028 | 0.03 | Melatonin 2 agonist | |||
| 0.092 | 0.09 | 0.092 | Factor V inhibitor | |||
| 0.02 | 0.018 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.026 | 0.025 | 0.026 | Estrogen-related receptor gamma antagonist | |||
| 0.052 | 0.051 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.019 | 0.018 | 0.019 | Retinoid X beta receptor agonist | |||
| 0.07 | 0.07 | 0.101 | Chymotrypsin inhibitor | 0.101 0.035 CID_187489 | CID_187489 | |
| 0.058 | 0.059 | 0.083 | Neuraminidase (influenza) inhibitor | 0.083 0.023 CID_187489 | CID_187489 | |
| 0.036 | 0.039 | 0.251 | Leukocyte elastase inhibitor | 0.251 0.004 CID_187489 | CID_187489 | |
| 0.019 | 0.023 | 0.025 | Dopamine D1 agonist | 0.025 0.012 CID_187489 | CID_187489 | |
| 0.029 | 0.033 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 CID_187489 | CID_187489 | |
| 0.021 | 0.032 | 0.121 | NMDA 2D receptor antagonist | 0.121 0.004 CID_187489 | CID_187489 | |
| 0.016 | 0.029 | 0.048 | Glutamate (mGluR1a) agonist | 0.048 0.005 CID_187489 | CID_187489 | |
| 0.047 | 0.062 | 0.062 | Neuraminidase inhibitor | 0.062 0.041 CID_187489 | CID_187489 | |
| 0.077 | 0.095 | 0.095 | Protein kinase C zeta inhibitor | 0.095 0.057 CID_187489 | CID_187489 | |
| 0.015 | 0.035 | 0.057 | Estrogen receptor beta agonist | 0.057 0.018 CID_187489 | CID_187489 | |
| 0.021 | 0.043 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 CID_187489 | CID_187489 | |
| 0.009 | 0.04 | 0.732 | Cholecystokinin A agonist | 0.732 0.001 CID_187489 | CID_187489 | |
| 0.172 | 0.206 | 0.508 | Angiogenesis inhibitor | 0.508 0.028 CID_187489 | CID_187489 | |
| 0.008 | 0.042 | 0.761 | Cholecystokinin agonist | 0.761 0.002 CID_187489 | CID_187489 | |
| 0.024 | 0.065 | 0.682 | Cholecystokinin B agonist | 0.682 0.001 CID_187489 | CID_187489 | |
| 0.017 | 0.058 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.016 CID_187489 | CID_187489 | |
| 0.04 | 0.091 | 0.088 | NMDA 2 receptor antagonist | 0.088 0.039 CID_187489 | CID_187489 | |
| 0.016 | 0.078 | 0.043 | 1,3-Beta-glucan synthase inhibitor | 0.043 0.003 CID_187489 | CID_187489 | |
| 0.018 | 0.09 | 0.058 | Dopamine D2 agonist | 0.058 0.022 CID_187489 | CID_187489 | |
| 0.026 | 0.105 | 0.116 | Carbonic anhydrase inhibitor | 0.116 0.022 CID_187489 | CID_187489 | |
| 0.006 | 0.088 | 0.072 | Estrone sulfatase inhibitor | 0.072 0.005 CID_187489 | CID_187489 | |
| 0.019 | 0.103 | 0.048 | Carbonic anhydrase I inhibitor | 0.048 0.045 CID_187489 | CID_187489 | |
| 0.007 | 0.11 | 0.395 | Cholecystokinin A antagonist | 0.395 0.003 CID_187489 | CID_187489 | |
| 0.008 | 0.128 | 0.346 | Cholecystokinin antagonist | 0.346 0.004 CID_187489 | CID_187489 | |
| 0.005 | 0.132 | 0.32 | Cholecystokinin B antagonist | 0.32 0.003 CID_187489 | CID_187489 | |
| 0.01 | 0.165 | 0.071 | Factor Xa inhibitor | 0.071 0.02 CID_187489 | CID_187489 | |
| 0.138 | 0.293 | 0.349 | Antiobesity | 0.349 0.087 CID_187489 | CID_187489 | |
| 0.015 | 0.178 | 0.04 | Purinergic P2Y2 antagonist | 0.04 0.016 CID_187489 | CID_187489 | |
| 0.028 | 0.212 | 0.105 | Thrombin inhibitor | 0.105 0.023 CID_187489 | CID_187489 | |
| 0.016 | 0.225 | 0.116 | Elastase inhibitor | 0.116 0.007 CID_187489 | CID_187489 | |
| 0.02 | 0.341 | 0.088 | Factor IXa inhibitor | 0.088 0.013 CID_187489 | CID_187489 | |
| 0.01 | 0.357 | 0.199 | NMDA 2B receptor antagonist | 0.199 0.005 CID_187489 | CID_187489 | |
| 0.004 | 0.511 | 0.047 | Factor XI inhibitor | 0.047 0.011 CID_187489 | CID_187489 | |
| 0.005 | 0.532 | 0.038 | Factor XIa inhibitor | 0.038 0.032 CID_187489 | CID_187489 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |